Lv2
168 积分 2023-05-29 加入
Efficacy, safety and immunogenicity of a recombinant human papillomavirus bivalent (types 16, 18) vaccine in healthy 18–30-year-old Chinese women: a phase III, double-blind, randomized, controlled trial
4个月前
已完结
Pulsed-field ablation: a revolution in atrial fibrillation therapy
9个月前
已完结
Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals
10个月前
已完结
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
10个月前
已完结
皖公网安备34019202002308
